Wordt geladen...
Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
OBJECTIVES: Traditional cancer therapy and regular immunotherapy are ineffective for treating triple‐negative breast cancer (TNBC) patients. Recently, chimeric antigen receptor‐engineered natural killer cells (CAR NK) have been applied to target several hormone receptors on different cancer cells to...
Bewaard in:
| Gepubliceerd in: | Cell Prolif |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445407/ https://ncbi.nlm.nih.gov/pubmed/32592435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12858 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|